Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jaime Branco

Showing results (41-50 of 75) with videos related to

Pageof 8
Sort By:
Arthritis and Rheumatism|February 1, 2007
Glucosamine sulfate in the treatment of knee osteoarthritis symptoms: a randomized, double-blind, placebo-controlled study using acetaminophen as a side comparatorGabriel Herrero-Beaumont, José Andrés Román Ivorra, María Del Carmen Trabado, et al.
Aging Clinical and Experimental Research|January 5, 2019
Patients' preferences for osteoarthritis treatment: the value of stated-preference studiesMickael Hiligsmann, Daniel Pinto, Elaine Dennison, et al.
Acta Reumatologica Portuguesa|August 26, 2010
[Acta Reumatologica Portuguesa: impact factor attributed in June 2010]João Eurico Fonseca, Maria José Santos, José António Pereira da Silva, et al.
Annals of the Rheumatic Diseases|May 7, 2017
EULAR recommendations for management of fibromyalgiaGary J Macfarlane, Caroline Kronisch, Fabiola Atzeni, et al.
Drugs & Aging|March 29, 2017
Erratum to: Can We Identify Patients with High Risk of Osteoarthritis Progression Who Will Respond to Treatment? A Focus on Epidemiology and Phenotype of OsteoarthritisOlivier Bruyère, Cyrus Cooper, Nigel Arden, et al.
Drugs & Aging|February 22, 2015
Can we identify patients with high risk of osteoarthritis progression who will respond to treatment? A focus on epidemiology and phenotype of osteoarthritisOlivier Bruyère, Cyrus Cooper, Nigel Arden, et al.
Frontiers in Public Health|July 24, 2025
When the lights went out: impacts of the April 2025 Iberian blackout on the Portuguese National Health Service sovereignty - a reflection on national defence, health sovereignty, risk, and infrastructural dependencyFrancisco Goiana-da-Silva, Daniel Madureira-Fonseca, Duarte Tude Graça, et al.
Seminars in Arthritis and Rheumatism|September 8, 2020
A discrete-choice experiment to assess patients' preferences for osteoarthritis treatment: An ESCEO working groupMickael Hiligsmann, Elaine Dennison, Charlotte Beaudart, et al.
Seminars in Arthritis and Rheumatism|May 26, 2019
An updated algorithm recommendation for the management of knee osteoarthritis from the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO)Olivier Bruyère, Germain Honvo, Nicola Veronese, et al.
Seminars in Arthritis and Rheumatism|February 5, 2019
Type 2 diabetes mellitus and osteoarthritisNicola Veronese, Cyrus Cooper, Jean-Yves Reginster, et al.
Pageof 8

Showing results (41-50 of 75) with videos related to

Sort By:
Pageof 8
Arthritis and Rheumatism|February 1, 2007
Glucosamine sulfate in the treatment of knee osteoarthritis symptoms: a randomized, double-blind, placebo-controlled study using acetaminophen as a side comparatorGabriel Herrero-Beaumont, José Andrés Román Ivorra, María Del Carmen Trabado, et al.
Aging Clinical and Experimental Research|January 5, 2019
Patients' preferences for osteoarthritis treatment: the value of stated-preference studiesMickael Hiligsmann, Daniel Pinto, Elaine Dennison, et al.
Acta Reumatologica Portuguesa|August 26, 2010
[Acta Reumatologica Portuguesa: impact factor attributed in June 2010]João Eurico Fonseca, Maria José Santos, José António Pereira da Silva, et al.
Annals of the Rheumatic Diseases|May 7, 2017
EULAR recommendations for management of fibromyalgiaGary J Macfarlane, Caroline Kronisch, Fabiola Atzeni, et al.
Drugs & Aging|March 29, 2017
Erratum to: Can We Identify Patients with High Risk of Osteoarthritis Progression Who Will Respond to Treatment? A Focus on Epidemiology and Phenotype of OsteoarthritisOlivier Bruyère, Cyrus Cooper, Nigel Arden, et al.
Drugs & Aging|February 22, 2015
Can we identify patients with high risk of osteoarthritis progression who will respond to treatment? A focus on epidemiology and phenotype of osteoarthritisOlivier Bruyère, Cyrus Cooper, Nigel Arden, et al.
Frontiers in Public Health|July 24, 2025
When the lights went out: impacts of the April 2025 Iberian blackout on the Portuguese National Health Service sovereignty - a reflection on national defence, health sovereignty, risk, and infrastructural dependencyFrancisco Goiana-da-Silva, Daniel Madureira-Fonseca, Duarte Tude Graça, et al.
Seminars in Arthritis and Rheumatism|September 8, 2020
A discrete-choice experiment to assess patients' preferences for osteoarthritis treatment: An ESCEO working groupMickael Hiligsmann, Elaine Dennison, Charlotte Beaudart, et al.
Seminars in Arthritis and Rheumatism|May 26, 2019
An updated algorithm recommendation for the management of knee osteoarthritis from the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO)Olivier Bruyère, Germain Honvo, Nicola Veronese, et al.
Seminars in Arthritis and Rheumatism|February 5, 2019
Type 2 diabetes mellitus and osteoarthritisNicola Veronese, Cyrus Cooper, Jean-Yves Reginster, et al.
Pageof 8